In 2010 a lawsuit filed on behalf of consumers who were supposedly required to pay greater prices for the antidepressant was denied the grant of Wellbutrin class action lawsuit certification by a federal judge. It was said that high rate was an outcome of GlaxoSmithKline’s attempts to keep a generic ...
